Virtual Pitch Feedback Session for Biotech, Pharma and Life Sciences Startups

We are happy to announce our next Virtual Pitch Feedback Session for Biotech, Pharma and Life Sciences start-ups with Dr. Angelika Vlachou, Partner at HTGF Berlin and Dr. Katharina Severin, Investment Manager at HTGF Bonn.

Are you a founder, entrepreneur or a researcher who wants to start a business? Then join our 1:1 pitch session and get early feedback from Dr. Angelika Vlachou and Dr. Katharina Severin on your 5-minute pitch. You can ask any questions you might have, such as:
What information is most relevant for an investor?
How to present information appropriately?
How to improve your presentation skills
.. and any other questions you might have on your mind!

To book a slot, please:

• register to the event: https://www.htgf.de/en/events/htgf-on-tour/virtual-pitch-feedback-session-life-science/
• use the video call link (Microsoft Teams) we will send to you 1 or 2 days prior to the event.

++ First come, first served ++

High-Tech Gründerfonds (HTGF) is Europe’s most active seed stage investor for highly innovative technologies across all sectors with a total
of around 900 million euros under management in three fund generations. We invest in people, provide them with venture capital to implement their high-tech ideas and innovative business models. Investing in high-tech startups is our passion. We understand our role in the start-up eco system by providing capital but also know-how and networks, especially in the early stages of a company´s development.

Dr. Angelika Vlachou has been investing venture capital in biotech, pharma and life science start-ups for more than 10 years. Over the course of her career, she has managed many transactions ranging from seed-stage venture capital and growth financing to licensing agreements, trade sale transactions and IPOs. Her expertise is also based on her virology and molecular biology research experience. One of her strengths is to combine scientific innovation with commercial potential. She is a valued sparring partner for founders, investors, and stakeholders. With a doctorate in biology, she started her professional career in investment banking. Angelica has just been promoted to Partner at Hight-Tech Gründerfonds.

Dr. Katharina Severin spent time in the US and Asia during her education. Among these stays was a one-year research stay in the lab of Tom Rapoport at Harvard Medical School in Boston. Katharina obtained her PhD in Medical Biology and received numerous scholarships and awards, among them stipends from the German National Academic Foundation and the Christiane Nüsslein-Volhard Foundation. Through networking opportunities from these foundations and as an attendee of the Lindau Nobel Laureate Meeting, Katharina discovered and cultivated her passion for interdisciplinary scientific exchange. Her research findings mark a starting point for a novel therapeutic approach in the treatment of cancer. Katharina is fascinated by entrepreneurial questions and is passionate about bringing scientific results and genious business ideas to profitable ventures.

We look forward to meeting you!

Your HTGF Berlin Team